Steroid-resistant nephrotic syndrome

Especially during the first infusion, the binding of muromonab-CD3 to CD3 can activate T cells to release cytokines like tumor necrosis factor and interferon gamma . This cytokine release syndrome , or CRS, includes side effects like skin reactions, fatigue , fever , chills , myalgia , headaches , nausea and diarrhea , [10] and could lead to life-threatening conditions like apnoea , cardiac arrest , and flash pulmonary edema . [6] To minimize the risk of CRS and to offset some of the minor side effects patient experience, glucocorticoids (such as methylprednisolone ), acetaminophen , and diphenhydramine are given before the infusion. [8]

Steroid-resistant nephrotic syndrome

steroid-resistant nephrotic syndrome

Media:

steroid-resistant nephrotic syndromesteroid-resistant nephrotic syndromesteroid-resistant nephrotic syndromesteroid-resistant nephrotic syndromesteroid-resistant nephrotic syndrome

http://buy-steroids.org